Chiesi Hellas S.A. - Greece
The year 2006 was a very successful year for the Greek affiliate. A 26% growth over 2005 was a significant result and at the same time a good sign that the affiliate is now able to set and meet even more challenging objectives in the future. The excellent sales development of Manyper® and Curosurf® established a solid base while the launch of Forair® and Budiair® in November gave a new area to the sales of the affiliate.

The basic objective with these two products is to successfully enter the highly competitive respiratory field, to gain reputation and to prepare the ground for the coming launch of Foster®.

To meet all these challenging goals, the affiliate is gradually expanding the sales force, planning further expansion for the launch of Foster®. The very good sales results of 2006, the launch of the respiratory product range and the pleasant expectation for new promising products, mainly in the respiratory portfolio, have created a new spirit in all of the company’s employees, who are determined to pursue even more challenging targets and achieve even better results in the future.

 
  Chiesi Hellas Pharmaceuticals S.A.
30 Anapafseos Av.
152 35 Vrilissa, Athens - Greece
Tel. +30 210 8104590 - Fax +30 210 8104594
Direttore Generale: George Moutousidis
  Copyright© 2007 Chiesi Farmaceutici SpA. All rights reserved. Last update: 30/06/2007 (final results 2006).
All mentions and descriptions of products solely provide information on Chiesi’s activities and are not intended to indicate the advisability of administering any product in any particular instance.